Literature DB >> 2614280

Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects.

A Avogaro1, D M Bier.   

Abstract

In this study we employed a capillary gas-liquid chromatographic-mass spectrometric (GLC-MS) method to measure the plasma concentrations of 3-hydroxybutyrate (3-OHB) and 3-hydroxyisobutyrate (3-OHIB) in overnight fasted diabetic subjects and in normal subjects. Plasma contents of 3-hydroxybutyrate measured in this fashion were identical to those obtained by enzymatic assay using a commercial preparation of beta-hydroxybutyrate dehydrogenase, indicating no significant contamination of this enzyme preparation with 3-hydroxyisobutyrate dehydrogenase. In normal individuals, plasma 3-OHIB concentration was 21 +/- 2 microM in the overnight fasted state and was higher in diabetic subjects (38 +/- 5 microM) and in subjects fasted for 72 h (97 +/- 4 microM). In the postabsorptive state, 3-OHIB was 33% the concentration of 3-OHB in normals and 17% that of 3-OHB in the diabetics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614280

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

Authors:  A Avogaro; A Valerio; L Gnudi; A Maran; M Miola; E Duner; C Marescotti; E Iori; A Tiengo; R Nosadini
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

2.  Effect of valine on myotube insulin sensitivity and metabolism with and without insulin resistance.

Authors:  Madison E Rivera; Emily S Lyon; Michele A Johnson; Kyle L Sunderland; Roger A Vaughan
Journal:  Mol Cell Biochem       Date:  2020-03-28       Impact factor: 3.396

3.  Cell Culture Medium Formulation and Its Implications in Cancer Metabolism.

Authors:  Tobias Ackermann; Saverio Tardito
Journal:  Trends Cancer       Date:  2019-05-29

4.  3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism.

Authors:  Mona S Nilsen; Regine Å Jersin; Arve Ulvik; André Madsen; Adrian McCann; Per-Arne Svensson; Maria K Svensson; Bjørn G Nedrebø; Oddrun A Gudbrandsen; Grethe S Tell; C R Kahn; Per M Ueland; Gunnar Mellgren; Simon N Dankel
Journal:  Diabetes       Date:  2020-06-25       Impact factor: 9.461

5.  A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control.

Authors:  Noha A Yousri; Dennis O Mook-Kanamori; Mohammed M El-Din Selim; Ahmed H Takiddin; Hala Al-Homsi; Khoulood A S Al-Mahmoud; Edward D Karoly; Jan Krumsiek; Kieu Trinh Do; Kieu Thinh Do; Ulrich Neumaier; Marjonneke J Mook-Kanamori; Jillian Rowe; Omar M Chidiac; Cindy McKeon; Wadha A Al Muftah; Sara Abdul Kader; Gabi Kastenmüller; Karsten Suhre
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

6.  Serum glycine is associated with regional body fat and insulin resistance in functionally-limited older adults.

Authors:  Michael S Lustgarten; Lori Lyn Price; Edward M Phillips; Roger A Fielding
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis.

Authors:  Anna Whitehead; Fynn N Krause; Amy Moran; Amanda D V MacCannell; Jason L Scragg; Ben D McNally; Edward Boateng; Steven A Murfitt; Samuel Virtue; John Wright; Jack Garnham; Graeme R Davies; James Dodgson; Jurgen E Schneider; Andrew J Murray; Christopher Church; Antonio Vidal-Puig; Klaus K Witte; Julian L Griffin; Lee D Roberts
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

8.  Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS.

Authors:  Teruo Miyazaki; Akira Honda; Tadashi Ikegami; Junichi Iwamoto; Tadakuni Monma; Takeshi Hirayama; Yoshifumi Saito; Kouwa Yamashita; Yasushi Matsuzaki
Journal:  Springerplus       Date:  2015-09-15

9.  A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.

Authors:  Cholsoon Jang; Sungwhan F Oh; Shogo Wada; Glenn C Rowe; Laura Liu; Mun Chun Chan; James Rhee; Atsushi Hoshino; Boa Kim; Ayon Ibrahim; Luisa G Baca; Esl Kim; Chandra C Ghosh; Samir M Parikh; Aihua Jiang; Qingwei Chu; Daniel E Forman; Stewart H Lecker; Saikumari Krishnaiah; Joshua D Rabinowitz; Aalim M Weljie; Joseph A Baur; Dennis L Kasper; Zoltan Arany
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440

10.  Higher Concentrations of BCAAs and 3-HIB Are Associated with Insulin Resistance in the Transition from Gestational Diabetes to Type 2 Diabetes.

Authors:  Ulrika Andersson-Hall; Carolina Gustavsson; Anders Pedersen; Daniel Malmodin; Louise Joelsson; Agneta Holmäng
Journal:  J Diabetes Res       Date:  2018-06-05       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.